Atea Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Atea Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Atea Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 7, 2024 was 84.4M shares, a 1.23% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 84.4M +1.02M +1.23% Aug 7, 2024 10-Q 2024-08-07
Q1 2024 84.2M +823K +0.99% Feb 25, 2024 10-K 2024-02-28
Q3 2023 83.4M +148K +0.18% Nov 7, 2023 10-Q 2023-11-08
Q2 2023 83.4M +141K +0.17% Aug 5, 2023 10-Q 2023-08-08
Q1 2023 83.3M +116K +0.14% Feb 25, 2023 10-K 2023-02-28
Q3 2022 83.3M +185K +0.22% Nov 4, 2022 10-Q 2022-11-07
Q2 2022 83.3M +482K +0.58% Aug 5, 2022 10-Q 2022-08-08
Q1 2022 83.2M +489K +0.59% Feb 25, 2022 10-K 2022-02-28
Q3 2021 83.1M Nov 10, 2021 10-Q 2021-11-12
Q2 2021 82.8M Aug 10, 2021 10-Q 2021-08-12
Q1 2021 82.7M Mar 29, 2021 10-K 2021-03-30
Q4 2020 82.6M Dec 10, 2020 10-Q 2020-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.